Clinical Trial

Muscle Health Measurements Using Electrical Impedance Myography

Recruiting
View on ClinicalTrials.gov →
Summary
This study is being done to further develop a device, the mScan, to measure muscle health as compared to measurements of muscle health using MRI (magnetic resonance imaging). This device is held against the skin and uses Electrical Impedance Myography (EIM). EIM uses a very small, noninvasive (e.g. no needles), brief (about 6 seconds), and painless electrical current to measure the muscle. The investigators will look at how the mScan predicts the muscle measurements seen on MRI in people with and without muscle disease. The investigators hope that this can be used in the future as a quick, convenient and less time-consuming way than MRI to assess muscle health. This could be used to measure how well treatments for different muscle disorders are working over a period of time.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-04-04
Trial Details
NCT Number NCT07502989
Lead Sponsor Beth Israel Deaconess Medical Center
Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Myolex, Inc
Conditions Myopathy, Muscular Dystrophies, Myositis, Myofibrillar Myopathy, Congenital Myopathy, Distal Myopathy, Myopathies
Enrollment 150 participants
Start Date 2025-04-09
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-04-03